Guild members are advised
that new conditions are
to apply to the dispensing
of dextropropoxyphene,
including Di-Gesic and
Doloxene. The conditions
have been imposed by the
Administrative Appeals
Tribunal, which allowed
the drug to remain on
the Australian Register of
Therapeutic Goods (ARTG),
but with conditions to
ensure the safe use of these
medicines.
The conditions require
the manufacturer Aspen
Pharmacare Australia to
have arrangements in
place designed to ensure
that doctors and dentists
complete and sign a new
Prescriber Confirmation Form
when prescribing Di-Gesic or
Doloxene and pharmacists
only dispense these
medicines if the patient has
provided a signed Prescriber
Confirmation Form.
For more information and
Questions and Answers for
consumers and pharmacists
click here.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Dec 13
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.